ABSTRACTTo determine the efficacy and tolerability of Unani drug preparations Hab-e-Surfa and Sharbat-e- Unab, we conducted the open labeled, non-comparative clinical trial focused on the patients of either sex in the age group between 14 to 60 years with upper respiratory disorders at Regional Research Institute of Unani medicine, University of Kashmir Srinagar from September 2012-September 2015 irrespective of socio economic status. After baseline assessment, a total number of 60 patients with upper respiratory tract disorders were treated with Hab-e-Surfa with the dose of 2 Tabs (Hab) twice a day and Sharbat-e- Unab 2 tsf twice a day for one week. Clinical assessment of disease were assessed at baseline and after treatment. The pre and post treatment score was compared statistically and recorded. From the result it was observed that Hab-e-Surfa and Sharbat-e- Unab significantly reduced all the signs and symptoms of upper respiratory tract troubles after one week treatment.  No adverse effect has been noticed during the study period. Hence it is concluded that Hab-e-Surfa and Sharbat-e-Unab acts as expectorant, lubricant ,concoctive, coolant, sedative, febrifuge, demulcent and is a promising Unani herbal preparation which is effective and safe. Keywords:  Sual, Clinical trial, Unani Medicine, Unab, Kashmir.